Infection in solid-organ transplant recipients.
Fishman
Jay A
JA
Transplant Infectious Disease and Compromised Host Program, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA. jfishman@partners.org
D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009894:Opportunistic Infections / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D016377:Organ Transplantation / Q000009:adverse effects*; D027601:Polyomavirus Infections / Q000175:diagnosis / Q000628:therapy; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control*; D012306:Risk; D014181:Transplantation Immunology
D000998:Antiviral Agents; D007166:Immunosuppressive Agents